Last edition
News about "halves risk of needing walking aid in relapsing mu"
These new analyses add additional evidence to the benefit-risk profile of OCREVUS, including the impact of MS on people's daily lives. The data were selected for the 72nd American Academy of Neurology (AAN) Annual Meeting and will be made available online via virtual presentation in the coming weeks
Halves Risk Of Needing Walking Aid In Relapsing Mu | 30/04/2020 | By Darshana | 190
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members